A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
NCT ID: NCT05020236
Last Updated: 2026-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
944 participants
INTERVENTIONAL
2021-10-04
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Part 1 of the study will assess the safety and activity of different doses of elranatamab in combination with daratumumab.
People participating in Part 2 of the study will be randomly assigned to receive either elranatamab alone, elranatamab plus daratumumab, or daratumumab, pomalidomide, and dexamethasone. Part 2 will evaluate the safety and activity of (1) elranatamab alone compared to daratumumab, pomalidomide, and dexamethasone, and (2) elranatamab plus daratumumab.
Part 3 will assess the effect of increased measures to protect against infection in people treated with either elranatamab alone or together with daratumumab.
All people participating in the study will receive study treatment until their disease progresses, they experience unacceptable side effects, or they choose to no longer participate in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Learn About Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant or Who Will Not Receive a Transplant as Initial Therapy
NCT05623020
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT06988488
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
NCT06152575
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
NCT05090566
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
NCT06183489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Part 1 Safety Lead-In Dose Escalation: Elranatamab + Daratumumab
Elranatamab
subcutaneous
Daratumumab
Daratumumab / hyaluronidase, subcutaneous
Part 2 Randomized Arm A: Elranatamab
Elranatamab
subcutaneous
Part 2 Randomized Arm B: Elranatamab + Daratumumab
Elranatamab
subcutaneous
Daratumumab
Daratumumab / hyaluronidase, subcutaneous
Part 2 Randomized Arm C: Daratumumab + Pomalidomide + Dexamethasone
Daratumumab
Daratumumab / hyaluronidase, subcutaneous
Pomalidomide
oral
Dexamethasone
oral
Part 3 Arm D: Elranatamab
Elranatamab
subcutaneous
Part 3 Arm E: Elranatamab + Daratumumab
Elranatamab
subcutaneous
Daratumumab
Daratumumab / hyaluronidase, subcutaneous
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elranatamab
subcutaneous
Daratumumab
Daratumumab / hyaluronidase, subcutaneous
Pomalidomide
oral
Dexamethasone
oral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Measurable disease based on IMWG criteria as defined by at least 1 of the following:
* Serum M-protein ≥0.5 g/dL.
* Urinary M-protein excretion ≥200 mg/24 hours.
* Serum immunoglobulin FLC ≥10 mg/dL (≥100 mg/L) AND abnormal serum immunoglobulin kappa to lambda FLC ratio (\<0.26 or \>1.65).
* Prior anti-multiple myeloma therapy including treatment with lenalidomide.
* ECOG performance status ≤2.
* Resolved acute effects of any prior therapy to baseline severity or CTCAE Grade ≤1.
* Not pregnant and willing to use contraception.
Exclusion Criteria
* Plasma cell leukemia.
* Amyloidosis.
* POEMS Syndrome.
* Stem cell transplant within 12 weeks prior to enrolment, or active graft versus host disease.
* Active HBV, HCV, SARS-CoV2, HIV, or any active, uncontrolled bacterial, fungal, or viral infection.
* Any other active malignancy within 3 years prior to enrolment, except for adequately treated basal cell or squamous cell skin cancer, or carcinoma in situ.
* Previous treatment with a BCMA-directed therapy.
* Live attenuated vaccine within 4 weeks of the first dose of study intervention.
* Administration with an investigational product (e.g. drug or vaccine) concurrent with study intervention or within 30 days preceding the first dose of study intervention used in this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clovis Community Medical Center
Clovis, California, United States
Community Cancer Institute
Clovis, California, United States
University of California San Francisco
Fresno, California, United States
Community Regional Medical Center
Fresno, California, United States
UCHealth Poudre Valley Hospital
Fort Collins, Colorado, United States
UCHealth Harmony
Fort Collins, Colorado, United States
UCHealth Greeley Hospital
Greeley, Colorado, United States
UCHealth - Medical Center of the Rockies
Loveland, Colorado, United States
Sylvester Comprehensive Cancer Center - Aventura
Aventura, Florida, United States
Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center
Coral Gables, Florida, United States
Sylvester Comprehensive Cancer Center - Coral Springs
Coral Springs, Florida, United States
University of Miami Hospital and Clinics - Deerfield Beach
Deerfield Beach, Florida, United States
Sylvester Comprehensive Cancer Center - Hollywood
Hollywood, Florida, United States
Griffin Cancer Research Building (GCRB)
Miami, Florida, United States
Sylvester Comprehensive Cancer Center
Miami, Florida, United States
University of Miami Hospital and Clinics
Miami, Florida, United States
Sylvester Comprehensive Cancer Center - Kendall
Miami, Florida, United States
Sylvester Comprehensive Cancer Center - Plantation
Plantation, Florida, United States
East Jefferson General Hospital
Metairie, Louisiana, United States
MSK Basking Ridge
Basking Ridge, New Jersey, United States
MSK Monmouth
Middletown, New Jersey, United States
MSK Bergen
Montvale, New Jersey, United States
MSK Commack
Commack, New York, United States
MSK Westchester
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).
New York, New York, United States
Memorial Sloan Kettering Cancer Center - Main Campus
New York, New York, United States
MSK Nassau
Uniondale, New York, United States
Alexander Fleming S.A (Instituto Medico Especializado Alexander Fleming)
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
FUNDALEU - Fundacion para combatir la Leucemia
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
FUNDALEU -Fundación para combatir la leucemia
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
FUNDALEU
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Hospital Italiano de La Plata
La Plata, Buenos Aires, Argentina
Hospital Universitario Austral
Presidente Derqui, Buenos Aires, Argentina
Sanatorio de La Mujer
Rosario, Santa Fe Province, Argentina
Pindara Private Hospital
Benowa, Queensland, Australia
QScan Radiology Clinics
Clayfield, Queensland, Australia
Gallipoli Medical Research Foundation
Greenslopes, Queensland, Australia
Greenslopes Private Hospital
Greenslopes, Queensland, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Epworth Freemasons
East Melbourne, Victoria, Australia
St Vincent's Hospital (Melbourne)
Fitzroy, Victoria, Australia
Barwon Health
Geelong, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Epworth Healthcare
Richmond, Victoria, Australia
Slade Pharmacy
Richmond, Victoria, Australia
Linear Clinical Research
Perth, Western Australia, Australia
Universitätsklinikum Krems
Krems, Lower Austria, Austria
Klinik Ottakring
Vienna, Vienna, Austria
Universitätsklinik für Innere Medizin V Innsbruck
Innsbruck, , Austria
Uniklinikum Salzburg
Salzburg, , Austria
Medizinische Universität Wien
Vienna, , Austria
Grand Hôpital de Charleroi
Gilly, Hainaut, Belgium
CHU UCL Namur (site Godinne)
Yvoir, Namur, Belgium
Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador
Salvador, Estado de Bahia, Brazil
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa
Porto Alegre, Rio Grande do Sul, Brazil
Centro de Pesquisa Clínica - Área Administrativa
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Mae de Deus
Porto Alegre, Rio Grande do Sul, Brazil
BP - A Beneficencia Portuguesa de São Paulo
São Paulo, São Paulo, Brazil
Clínica Médica São Germano LTDA
SP, São Paulo, Brazil
Hospital Américas Medical City
Rio de Janeiro, , Brazil
Instituto de Educação, Pesquisa e Gestão em Saúde
Rio de Janeiro, , Brazil
ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis
São Paulo, , Brazil
IDOR Ensino e Pesquisa
São Paulo, , Brazil
HU UNIFESP / SPDM - Hospital São Paulo
São Paulo, , Brazil
Universidade Federal de Sao Paulo
São Paulo, , Brazil
Clínica Médica São Germano S/S Ltda
São Paulo, , Brazil
Instituto D'Or de Pesquisa e Ensino (IDOR)
São Paulo, , Brazil
Instituto D'Or de Pesquisa e Ensino (IDOR)
São Paulo, , Brazil
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
QEII Health Sciences Centre - Victoria General Site
Halifax, Nova Scotia, Canada
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Hamilton Health Sciences-Juravinski Cancer Centre
Hamilton, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
CIUSSS de l'Est-de-l'Île-de-Montréal
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Saskatoon Cancer Center
Saskatoon, Saskatchewan, Canada
Peking University Third Hospital
Beijing, Beijing Municipality, China
Beijing Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Nanjing Drum Tower Hospital ， The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Jilin Province Cancer Hospital
Changchun, Jilin, China
The First Hospital of Jilin University
Changchun, Jilin, China
Shandong Provincial Hospital
Jinan, Shandong, China
Jinan Central Hospital
Jinan, Shandong, China
Institute of hematology&blood disease hospital
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital, Zhejiang University
Hangzhou, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Beijing Boren Hospital
Beijing, , China
Chongqing University Cancer Hospital
Chongqing, , China
Fakultní nemocnice Brno Bohunice
Brno, Brno-m?sto, Czechia
Fakultni Nemocnice Plzen
Plzen - Lochotin, Plzeň Region, Czechia
Fakultni poliklinika
Prague, Praha 2, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, , Czechia
Fakultni nemocnice Olomouc
Olomouc, , Czechia
Fakultni nemocnice Ostrava
Ostrava-Poruba, , Czechia
Vseobecna fakultni nemocnice v Praze
Prague, , Czechia
Kuopion Yliopistollinen Sairaala
Kuopio, Northern Savonia, Finland
Tampereen yliopistollinen sairaala
Tampere, Pirkanmaa, Finland
Turku University Hospital
Turku, Southwest Finland, Finland
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)
Helsinki, , Finland
Oulun yliopistollinen sairaala
Oulu, , Finland
Tampereen yliopistollinen sairaala
Tampere, , Finland
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren
Limoges, Limousin, France
Hopital Claude Huriez - CHU de Lille
Lille, NORD, France
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
Nantes, , France
Hopital Necker
Paris, , France
Hôpital Saint Antoine
Paris, , France
Centre Hospitalier Lyon Sud - Service d'Hematologie Clinique
Pierre-Bénite, , France
CHU de Poitiers, Hôpital de la Milétrie, Pôle Régional de Cancérologie
Poitiers, , France
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE
Toulouse, , France
Universitaetsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany
Charité Universitätsmedizin Berlin
Berlin, , Germany
Staedtisches Klinikum Braunschweig gGmbH
Braunschweig, , Germany
Klinikum Chemnitz gGMbH
Chemnitz, , Germany
Universitätsklinikum rechts der Isar, Technische Universität München (TUM)
München, , Germany
Evangelismos General Hospital of Athens
Athens, Attikí, Greece
Radiology vendor
Athens, Attikí, Greece
Alexandra General Hospital of Athens
Athens, Attikí, Greece
Theageneio Cancer Hospital of Thessaloniki
Thessaloniki, Kentrikí Makedonía, Greece
University General Hospital of Ioannina
Ioannina, , Greece
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"
Meldola, Emilia-Romagna, Italy
Ospedale San Martino
Genoa, Liguria, Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, Italy
Fondazione IRCCS San Gerardo dei Tintori
Monza, Lombardy, Italy
ASST Santi Paolo e Carlo Ospedale San Carlo Borromeo SSD di Onco-Ematologia (Edificio C-piano terra)
Milan, Milan, Italy
Policlinico "G. Rodolico"
Catania, Sicily, Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
Bologna, , Italy
AOU Policlinico Umberto I
Roma, , Italy
Fondazione Policlinico Universitario Agostino Gemelli
Roma, , Italy
Nagoya City University Hospital
Nagoya, Aichi-ken, Japan
University of Fukui Hospital
Yoshida-gun, Fukui, Japan
National Hospital Organization Shibukawa Medical Center
Shibukawa, Gunma, Japan
Iwate Medical University Hospital
Yahaba-cho, Iwate, Japan
Tohoku University Hospital
Sendai, Miyagi, Japan
Shizuoka Cancer Center
Sunto-gun, Shizuoka, Japan
Japanese Red Cross Medical Center
Shibuya-ku, Tokyo, Japan
Akita University Hospital
Akita, , Japan
National Hospital Organization Kyushu Cancer Center
Fukuoka, , Japan
Kagoshima University Hospital
Kagoshima, , Japan
National Hospital Organization Kumamoto Medical Center
Kumamoto, , Japan
Nagasaki University Hospital
Nagasaki, , Japan
National Hospital Organization Okayama Medical Center
Okayama, , Japan
Osaka Metropolitan University Hospital
Osaka, , Japan
Tokushima University Hospital
Tokushima, , Japan
Yamagata University Hospital
Yamagata, , Japan
Hematológica Alta Especialidad SC, consultorio 830
Colonia Valle de Las Palmas, México, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico
Centro de Investigacion Clinica de Oaxaca
Oaxaca City, , Mexico
Instituto Veracruzano en Investigación Clínica S.C.
Veracruz, , Mexico
Erasmus Universitair Medisch Centrum
Rotterdam, South Holland, Netherlands
Maastricht University Medical Center
Maastricht, , Netherlands
North Shore Hospital
Auckland, , New Zealand
Labtests Auckland Ltd.
Auckland, , New Zealand
Aotearoa Clinical Trials
Auckland, , New Zealand
Waikato District Health Board, Waikato Hospital
Hamilton, , New Zealand
TRG Imaging
Milford, , New Zealand
Pacific Radiology
Newtown, , New Zealand
Broadway Radiology
Palmerston North, , New Zealand
Palmerston North Hospital
Roslyn, , New Zealand
Pharmacy on Shakespeare
Takapuna, , New Zealand
Capital, Coast and Hutt Valley District - Wellington Regional Hospital
Wellington, , New Zealand
Haukeland Universitetssjukehus
Bergen, Hordaland, Norway
Stavanger Universitetssykehus
Stavanger, Rogaland, Norway
Oslo Universitetssykehus Ullevål
Oslo, , Norway
St Olavs Hospital
Trondheim, , Norway
Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy Klinika Hematologii
Bydgoszcz, , Poland
Uniwersyteckie Centrum Kliniczne
Gdansk, , Poland
Pratia Onkologia Katowice
Katowice, , Poland
Uniwersytecki Szpital Kliniczny w Poznaniu
Poznan, , Poland
Centrum Medyczne Pratia Poznan
Skorzewo, , Poland
Uniwersyteckie Centrum Kliniczne WUM Centralny Szpital Kliniczny
Warsaw, , Poland
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Wroclaw, , Poland
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Chonnam National University Hwasun Hospital
Hwasun-gun, Jeonranamdo, South Korea
Pusan National University Hospital
Busan, Pusan-kwangyǒkshi, South Korea
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [seoul], South Korea
The Catholic Univ. of Korea Seoul St. Mary's Hospital
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Kyungpook National University Hospital
Daegu, Taegu-kwangyǒkshi, South Korea
Gachon University Gil Medical Center
Incheon, , South Korea
Asan Medical Center
Seoul, , South Korea
Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, A Coruna, Spain
Institut Català d'Oncologia - L'Hospitalet
L'Hospitalet Del Llobregat, Barcelona [barcelona], Spain
Hospital Universitari Mutua Terrassa
Terrassa, Barcelona, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Clinica Universidad de Navarra
Pamplona, Navarre, Spain
Hospital Universitario de Toledo
Toledo, Other, Spain
Hospital Universitari Vall d'Hebron
Barcelona, , Spain
Hospital Clinic Barcelona
Barcelona, , Spain
Hospital Universitari De Girona Doctor Josep Trueta
Girona, , Spain
Hospital Universitario La Princesa
Madrid, , Spain
Hospital Universitario Madrid Sanchinarro
Madrid, , Spain
Hospital Universitario de Salamanca
Salamanca, , Spain
Hospital Universitario Virgen Del Rocio
Seville, , Spain
Hospital Universitario y Politecnico La Fe
Valencia, , Spain
Skånes Universitetssjukhus Lund
Lund, Skåne LÄN [se-12], Sweden
Södra Älvsborg Sjukhus
Borås, , Sweden
Falu Lasarett
Falun, , Sweden
Sahlgrenska Universitetssjukhuset
Gothenburg, , Sweden
Sunderby Sjukhus
Luleå, , Sweden
Universitetssjukhuset Örebro
Örebro, Örebro LÄN [se-18], Sweden
Läkemedelsberedningen
Linköping, Östergötlands LÄN [se-05], Sweden
Universitetssjukhuset i Linköping
Linköping, Östergötlands LÄN [se-05], Sweden
Chang Gung Memorial Hospital at Kaohsiung
Kaohsiung City, , Taiwan
China Medical University Hospital
Taichung, , Taiwan
National Cheng Kung University Hospital
Tainan, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Istanbul Universitesi Istanbul Tıp Fakultesi Hastanesi
Istanbul, İ̇stanbul, Turkey (Türkiye)
Medipol Mega Universite Hastanesi
Istanbul, İ̇stanbul, Turkey (Türkiye)
Acibadem Universitesi Atakent Hastanesi
Istanbul, İ̇stanbul, Turkey (Türkiye)
Sisli Florence Nightingale Hastanesi
Istanbul, İ̇stanbul, Turkey (Türkiye)
Ege Universitesi Hastanesi
Izmir, İ̇zmir, Turkey (Türkiye)
Dokuz Eylul Universitesi Hastanesi
Izmir, İ̇zmir, Turkey (Türkiye)
Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi
Adana, , Turkey (Türkiye)
Ankara University Health Practice and Research Hospitals
Ankara, , Turkey (Türkiye)
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi
Ankara, , Turkey (Türkiye)
Akdeniz Universitesi Hastanesi
Antalya, , Turkey (Türkiye)
Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
Gaziantep, , Turkey (Türkiye)
Erciyes Universitesi Tıp Fakultesi Hastaneleri
Kayseri, , Turkey (Türkiye)
Özel Anadolu Sağlık Merkezi
Kocaeli, , Turkey (Türkiye)
Inonu Universitesi Turgut Ozal Tıp Merkezi
Malatya, , Turkey (Türkiye)
Royal Bournemouth Hospital
Bournemouth, Dorset, United Kingdom
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom
University Hospital of Wales
Cardiff, South Glamorgan, United Kingdom
Bristol Haematology and Oncology Centre
Bristol, , United Kingdom
Kent and Canterbury Hospital
Canterbury, , United Kingdom
The Christie NHS Foundation Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAGNETISMM-5
Identifier Type: OTHER
Identifier Source: secondary_id
2023-509208-14-00
Identifier Type: REGISTRY
Identifier Source: secondary_id
C1071005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.